Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19

Hamidreza Jamaati; Payam Tabarsi; Naghmeh Bahrami; Fatemeh  Yasari; Mohammad  Varahram; Mehdi Kazempour Dizaji; Seyed Mohammadreza Hashemian; Mahya  Daustany; Maral  Emami; Sadegh Shirian; Ladan  Masumi; Amir  Rasouli; Armita  Narimani; Nasser   Ahmadian; Abdolreza Mohamadnia; Ali Akbar  Velayati

doi:10.22037/jcma.v6i2.34671

Journal of Cellular & Molecular Anesthesia

Journal Information Editors & Boards Indexing and Listing Sources Open Peer Review (OPR)Journal Metrics Publication Ethics and Malpractice Statement Reviewer and AE Registration Form New Publisher Announcement Support Contact Us

APC

Authors Guide Submit Manuscript

https://doi.org/10.22037/jcma.v6i2.34671

Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19

Author(s):

Hamidreza Jamaati

^,*,

Payam Tabarsi

,

Naghmeh Bahrami

,

Fatemeh Yasari,

Mohammad Varahram,

Mehdi Kazempour Dizaji,

Seyed Mohammadreza Hashemian,

Mahya Daustany ,

Maral Emami ,

Sadegh Shirian

,

Ladan Masumi ,

Amir Rasouli,

Armita Narimani,

Nasser Ahmadian,

Abdolreza Mohamadnia

¹,

Ali Akbar Velayati

1PhD of Molecular Medicine, Virology Research Center, National Research Institute of Tuberculosis & Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran

Journal of Cellular & Molecular Anesthesia:Vol. 6, issue 2; e149671

Published online:May 15, 2021

Article type:Original Articles

How to Cite:Hamidreza Jamaati, Payam Tabarsi, Naghmeh Bahrami, Fatemeh Yasari, Mohammad Varahram, et al. Clinical Significance and Different Expression of Dipeptidyl Peptidase IV and Procalcitonin in Mild and Severe COVID-19.J Cell Mol Anesth.2021;6(2):e149671.https://doi.org/10.22037/jcma.v6i2.34671.

Abstract

Background: Coronavirus has become a global concern in 2019-20. The virus belongs to the coronavirus family, which has been able to infect many patients and victims around the world. The virus originated in the Chinese city of Wuhan, which eventually spread around the world and became a pandemic. Materials and Methods: A total of 60 Patients with severe (n=30) and mild (n=30) symptoms of COIVD-19 were included in this study. Peripheral blood samples were collected from the patients. Real-time PCR was used to compare the relative expression levels of Procalcitonin and dipeptidyl peptidase IV (DPPIV) in a patient with severe and mild Covid-19 infection. Results: Procalcitonin and dipeptidyl peptidase IV markers in the peripheral blood of patients with severe symptoms, were positive in 29 (96.60%) and 26 (86.60%), respectively (n=30); however, positive rates in the mild symptoms patients group were 27 (90%) and 25 (83.30%), respectively. There was a statistically significant difference between these two groups in terms of DDPIV and Procalcitonin (p<0.001). Conclusion: Procalcitonin and DPPIV increase in patients with COVID-19 infection, significantly higher in the patients with more severe clinical symptoms than those with milder ones. More studies will be needed to verify the reliability of the current findings. Keywords: Procalcitonin, DPPIV, Severe symptoms, Mild symptoms, COVID-19

Keywords

Procalcitonin

Dipeptidyl peptidase-4

Severe symptoms

Mild symptoms

COVID-19

References

1.
References are in the PDF file of the article.

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

CrossRef 0

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Hamidreza Jamaati:[PubMed][Scholar]
Payam Tabarsi:[PubMed][Scholar]
Naghmeh Bahrami:[PubMed][Scholar]
Fatemeh Yasari:[PubMed][Scholar]
Mohammad Varahram:[PubMed][Scholar]
Mehdi Kazempour Dizaji:[PubMed][Scholar]
Seyed Mohammadreza Hashemian:[PubMed][Scholar]
Mahya Daustany :[PubMed][Scholar]
Maral Emami :[PubMed][Scholar]
Sadegh Shirian:[PubMed][Scholar]
Ladan Masumi :[PubMed][Scholar]
Amir Rasouli:[PubMed][Scholar]
Armita Narimani:[PubMed][Scholar]
Nasser Ahmadian:[PubMed][Scholar]
Abdolreza Mohamadnia:[PubMed][Scholar]
Ali Akbar Velayati:[PubMed][Scholar]